Sloning BioTechnology

About:

Sloning Bio Technology offers tailored protein engineering solutions to the industrial and biopharmaceutical sectors.

Top Investors: KfW, LBBW VC, HBM Partners, HBM Healthcare Investments, Deutsche Effecten -und Wechsel Beteiligungsgesellschaft

Description:

Sloning BioTechnology has developed a unique and patented technology platform to build DNA molecules with exceptional features regarding sequence limitations, reliability and production cost on an industrial scale robotic system the Slonomics technology platform.

Total Funding Amount:

12.1M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Puchheim, Bayern, Germany

Founded Date:

2000-01-01

Contact Email:

info(AT)sloning.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-09-21

IPO Status:

Private

Industries: